Sleep drug shows promise in rewiring stress response in heavy drinkers

NCT ID NCT05656534

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 23 times

Summary

This early-phase study tested whether suvorexant, a sleep medication, could change how the brain and body respond to stress in people with moderate to severe alcohol use disorder. 81 adults took either suvorexant or a placebo nightly for 4 weeks, while researchers measured their startle response to threats and tracked their drinking. The goal was to understand if the drug affects stress-related brain activity and whether that leads to less heavy drinking.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • The Ohio State University

    Columbus, Ohio, 43210, United States

Conditions

Explore the condition pages connected to this study.